Molecure S.A. Logo

Molecure S.A.

Clinical-stage biotech developing small molecule drugs for oncology and fibrotic diseases.

MOC | WAR

Overview

Corporate Details

ISIN(s):
PLONCTH00011
LEI:
2594003L11V38ZCVKZ09
Country:
Poland
Address:
Warszawa Żwirki i Wigury 101, 02-089 Warszawa

Description

Molecure S.A. is a clinical-stage biotechnology company focused on discovering and developing first-in-class small molecule drugs for diseases with high unmet medical needs. The company utilizes its expertise in medicinal chemistry and biology to identify, validate, and modulate novel protein and mRNA targets. Its therapeutic pipeline is concentrated on oncological, inflammatory, and fibrotic diseases. Molecure operates a proprietary discovery platform for targeting mRNA with small molecules, enabling the development of innovative therapies for previously untreatable conditions.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-09 15:22
Podpisanie umowy o dofinansowanie z Narodowym Centrum Badań i Rozwoju. - Conten…
Polish 2.1 KB
2025-11-24 18:56
Rejestracja zmiany Statutu Spółki - Content (PL)
Polish 10.9 KB
2025-10-27 07:11
Skonsolidowany raport Grupy Kapitałowej za III kwartał 2025 roku
Polish 2.6 MB
2025-10-22 19:50
Zmiana terminu publikacji raportu za III kwartał 2025 roku. - Content (PL)
Polish 917 bytes
2025-10-21 16:00
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Nadzwyczajnym…
Polish 2.0 KB
2025-10-21 15:46
Treść powziętych uchwał
Polish 229.8 KB
2025-10-21 15:46
Treść uchwał podjętych przez Nadzwyczajne Walne Zgromadzenie w dniu 21 paździer…
Polish 686 bytes
2025-09-30 07:56
Raport z przeglądu SSF 30.06.2025
Polish 236.4 KB
2025-09-30 07:56
Raport z przeglądu JSF 30.06.2025
Polish 233.4 KB
2025-09-30 07:56
Sprawozdanie Zarządu z działalności Molecure S.A. 30.06.2025
Polish 1.5 MB
2025-09-30 07:56
Skonsolidowane Sprawozdanie Finansowe Molecure S.A. 30.06.2025
Polish 1.1 MB
2025-09-30 07:56
Jednostkowe Sprawozdanie Finansowe Molecure S.A. 30.06.2025
Polish 1.2 MB
2025-09-26 17:16
Informacja o pozytywnej ocenie wniosku Spółki w ramach ścieżki "SMART" - Projek…
Polish 2.5 KB
2025-09-23 15:18
Zaktualizowane projekty uchwał
Polish 225.0 KB
2025-09-23 15:18
Aktualizacja Zarządu dotycząca projektu Uchwały Nadzwyczajnego Walnego Zgromadz…
Polish 4.9 KB

Automate Your Workflow. Get a real-time feed of all Molecure S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Molecure S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Molecure S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

genOway Logo
Designs and develops genetically modified preclinical models for research.
France
ALGEN
Genprex, Inc. Logo
Clinical-stage gene therapy company developing therapies for cancer and diabetes.
United States of America
GNPX
Genxone Spolka Akcyjna Logo
A biotechnology company specializing in Next Generation Sequencing and medical diagnostics.
Poland
GX1
GeoVax Labs, Inc. Logo
Clinical-stage biotech developing vaccines and therapies for infectious diseases and cancer.
United States of America
GOVX
GH Research PLC Logo
Develops mebufotenin-based therapies for psychiatric and neurological disorders.
United States of America
GHRS
GI Innovation Inc. Logo
Researches and develops protein-based drugs for immuno-oncology and immunology.
South Korea
358570
Ginkgo Bioworks Holdings, Inc. Logo
Operates a horizontal platform for cell programming and synthetic biology.
United States of America
DNA
GRAIL, Inc. Logo
A healthcare company developing blood tests for multi-cancer early detection.
United States of America
GRAL
GT Biopharma, Inc. Logo
Clinical-stage immuno-oncology company developing therapies with its NK cell engager tech.
United States of America
GTBP
Guard Therapeutics International AB Logo
Clinical-stage biotech developing therapies to prevent acute kidney injury.
Sweden
GUARD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.